LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
ClosedPublished 4 May 2026

Gyre Therapeutics, Inc. /
Cullgen

Gyre Therapeutics, Inc. completes purchase of Cullgen

Buy side: Gyre Therapeutics, Inc.
Buy sideGyre Therapeutics, Inc.
Target: Cullgen
TargetCullgen
Gyre Therapeutics, Inc. · 4 May 2026Source
See the source
Buy side: Gyre Therapeutics, Inc.
Buy sideGyre Therapeutics, Inc.
Target: Cullgen
TargetCullgen
01 / BuyerGyre Therapeutics, Inc.
02 / TargetCullgen
Source for the buyer and target: Gyre Therapeutics, Inc.

For the buyer and target.

“On May 4, 2026 (the “Closing Date”), Gyre Therapeutics, Inc., a Delaware corporation (the “Company” or “Gyre”), consummated the previously announced acquisition of Cullgen Inc., a Delaware corporation (“Cullgen”), in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated March 2, 2026 (the “Merger Agreement”), by and among the Company, Helix Merger Sub Corp., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”), and Cullgen.”

Published 4 May 2026

Open the source
01

What happened

Gyre Therapeutics, Inc. completed its acquisition of Cullgen for approximately $300 million, according to a filing dated May 4, 2026. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc. completes purchase of Cullgen

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    “Gyre Therapeutics, Inc. completes purchase of Cullgen Gyre Therapeutics, Inc. completed its acquisition of Cullgen for approximately $300 million, according to a filing dated May 4, 2026”

    Open the source

  2. Published by Gyre Therapeutics, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.